Western blot analysis of these lymphangiomas indicated that phosphorylation of VEGFR-2 and VEGFR-3 decreased by 2.5-fold and 2.8-fold as a result of anlotinib treatment (Figure 5E and 5F). Here, KDR is linked to lymphangioma.